Hence, CRP and ESR may contribute to atherosclerosis progression through endothelial NO synthase inhibition, cytokine production, generation of reactive oxygen species by monocytes and neutrophils, vascular stiffness, T cell migration, and activation as suggested in other cardiovascular diseases (Mozos et al., 2017). The gene discussed is CRP; the disease is atherosclerosis.